Skip to main content

Table 1 Demographics of the study participants

From: The Kickstart Walk Assist System for improving balance and walking function in stroke survivors: a feasibility study

Subject #

Stroke diagnosis

Age (years)

Sex

Side impaired

Disease onset (months)

Assistive device

Exotendon Scale (0-N)

1

Hemorrhagic

53

Male

Right

5

None

0

2

Ischemic

60

Male

Left

11

None

0

3

Hemorrhagic

65

Female

Left

9

Walker

0

4

Ischemic

53

Male

Right

4

None

0

5

Ischemic

57

Male

Left

7

None

0

6

Hemorrhagic

38

Male

Left

28

Crutch

0

7

Ischemic

50

Male

Right

5

None

0

8

Ischemic

62

Male

Right

2

None

0

9

Hemorrhagic

38

Male

Left

6

Walker

0

10

Ischemic

51

Male

Right

12

None

0

11

Hemorrhagic

27

Female

Right

3

Walker

5

12

Ischemic

51

Male

Right

3

Walker

5–7

13

Hemorrhagic

52

Male

Right

3

None

4–6

14

Hemorrhagic

32

Male

Right

19

None

5–6

15

Ischemic

61

Male

Left

10

Crutch

6

16

Ischemic

48

Male

Left

1

None

7

17

Ischemic

55

Male

Left

2

None

6

18

Ischemic

55

Male

Right

3

None

7

19

Ischemic

46

Male

Right

6

None

5

20

Ischemic

63

Male

Left

4

Walker

7

21

Ischemic

60

Male

Right

13

Walker

6

22

Hemorrhagic

76

Female

Left

7

Crutch

5

23

Ischemic

79

Male

Right

6

Walker

7

24

Hemorrhagic

58

Male

Left

15

Crutch

6

25

Ischemic

26

Male

Left

4

None

7

26

Ischemic

42

Male

Left

6

None

5

27

Ischemic

68

Male

Left

4

Crutch

6

28

Ischemic

52

Male

Right

11

Walker

5

29

Ischemic

52

Male

Right

5

None

5

30

Hemorrhagic

47

Male

Right

4

Walker

5

N = 30

Hemorrhagic = 10

Ischemic = 20

52.57 ± 2.28

Male = 27

Female = 3

Right = 16

Left = 14

7.27 ± 1.05

Device = 14

None = 16

Range 4–7

  1. The last row provides the total number of subjects as well as the break-up of hemorrhagic/ischemic, male/female, right/left affected, and the use of assistive/no devices used. In addition, it also provides the mean ± standard deviations for the age, disease duration and also the range of Exotendon stiffness scale